Investors

Home > Investors > Financial Overview > 5 Year Overview Summary

US GAAP
Please note: The content of this file is qualified in its entirety by reference to the electronic version of the ASML 2017 Integrated Report based on US GAAP and therefore: (i) your local settings can influence the way this table and its content is being displayed and (ii) (foot)notes have been deleted for reader's convenience.

Income statement (€ million)	2013	2014	2015	2016	2017
Net sales	5,245	5,856	6,287	6,795	9,053
Gross profit	2,177	2,596	2,896	3,045	4,077
R&D costs, net of credits	-882	-1,074	-1,068	-1,106	-1,260
SG&A costs	-312	-321	-346	-375	-417
Income (loss) from operations	1,048	1,282	1,565	1,658	2,496
Net income (loss)	1,016	1,197	1,387	1,472	2,119
Gross margin	42%	44%	46%	45%	45%
Operating margin	20%	22%	25%	24%	28%

Balance sheet (€ million)	2013	2014	2015	2016	2017
Cash & cash equivalents and short term investments	3,011	2,754	3,409	4,057	3,288
Working capital*	4,157	4,257	4,600	5,277	5,665
Total assets	11,514	12,204	13,295	17,206	18,196
Long term debt	1,075	1,154	1,130	3,320	3,025
Shareholders equity	6,922	7,513	8,389	9,820	10,676

*Working Capital is calculated as the difference between total current assets, including cash and cash equivalents, and total current liabilities.

Cash flow statement (€ million)	2013	2014	2015	2016	2017
Net cash provided by operating activities	1,054	1,025	2,026	1,666	1,799
Net cash used in investing activities	-368	-16	-1,160	-3,189	-1,209
Net cash provided by (used in) financing activities	-113	-928	-834	1,964	-1,209
Net increase (decrease) in cash & cash equivalents	563	89	39	448	-648

Earnings per share data ( € )	2013	2014	2015	2016	2017
Basic net income per share	2.36	2.74	3.22	3.46	4.93
Diluted net income per share	2.34	2.72	3.21	3.44	4.91
Number of shares used in computing per share amounts
Basic (millions)	430	437	431	426	430
Diluted (millions)	433	440	433	428	432